Cognition Therapeutics, Inc.
CGTX
$0.3724
-$0.0008-0.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 12.29M | 13.31M | 13.32M | 13.53M | 13.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.97M | 58.43M | 58.71M | 55.85M | 50.72M |
| Operating Income | -53.97M | -58.43M | -58.71M | -55.85M | -50.72M |
| Income Before Tax | -33.97M | -34.27M | -31.08M | -28.77M | -25.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -33.97 | -34.27 | -31.08 | -28.77 | -25.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -33.97M | -34.27M | -31.08M | -28.77M | -25.79M |
| EBIT | -53.97M | -58.43M | -58.71M | -55.85M | -50.72M |
| EBITDA | -53.86M | -58.33M | -58.61M | -55.75M | -50.63M |
| EPS Basic | -0.87 | -0.96 | -0.93 | -0.92 | -0.86 |
| Normalized Basic EPS | -0.71 | -0.76 | -0.75 | -0.74 | -0.54 |
| EPS Diluted | -0.88 | -0.97 | -0.94 | -0.92 | -0.86 |
| Normalized Diluted EPS | -0.71 | -0.76 | -0.75 | -0.74 | -0.54 |
| Average Basic Shares Outstanding | 158.90M | 145.24M | 135.19M | 124.74M | 120.10M |
| Average Diluted Shares Outstanding | 158.90M | 145.24M | 135.19M | 124.74M | 120.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |